Kamedis Overview
Kamedis develops effective, dermatologist-tested, botanical skin care products for a variety of chronic skin conditions including eczema, acne, dandruff, psoriasis, dry skin, and itchy/irritated skin. The company's botanicals are produced in a certified manufacturing facility, ensuring the quality and production consistency of the botanical extracts. The extraction technique is developed to maximize formulation potency. All final products have been validated by dermatologists, backed by dozens of clinical trials, and received strong endorsement from consumers. Launched in Israel in 2003 and now also sold in the United States, China, Taiwan, the Philippines, Singapore, and several European countries, the company's products are based on extensive scientific research and development, which included hundreds of traditional Chinese medicine botanicals and their combinations.
Latest News
growth-positive
Eczema patients with dark skin do better with botanical-based treatment Atlanta Daily World
Kamedis Botanical-based Eczema Therapy Cream is more effective in treating atopic dermatitis in skin of color compared to non-botanical OTC products, according to a study. The product demonstrated higher efficacy in improving skin appearance and reducing affected disease area. Atopic dermatitis is prevalent among African-Americans, especially children. The study results highlight the effectiveness of Kamedis patented formulation containing Chinese Rhubarb, Great Burnet, Tree of Heaven, Baikal Skullcap, Cnidium Fruit, and Licorice extracts. The findings provide a potential growth opportunity for Kamedis in the skincare market.
Customers
growth-positive
Kamedis Clinical Study Validates Traditional Chinese Botanical Efficacy in Eczema Treatment
Kamedis, a provider of advanced botanical solutions for chronic skin disorders, has announced the results of a clinical study confirming the efficacy of traditional Chinese botanicals in its over-the-counter Kamedis Calm Eczema Therapy Cream. The study found that the cream was 44% more effective in treating atopic dermatitis than the Kamedis formula without the botanical extracts, and 23% more effective than a competitive OTC brand. The study is the first in the U.S. to determine the efficacy of traditional Chinese botanicals in commercial dermatologic treatments.
Customers
growth-positive
Kamedis Receives Notice of Allowance for First US Patent on Botanical Eczema Treatment
Kamedis has received a Notice of Allowance for a patent application involving their Kamedis Calm Eczema Therapy Cream. The patent will protect the products proprietary combination of traditional Chinese botanicals used to treat eczema-related inflammation and infection. The cream has been clinically proven to reduce eczema flare-ups by 50% in two weeks. Kamedis is also conducting a clinical trial to examine the effectiveness of the botanical ingredients in the healing process. The companys product line includes botanical-based treatments for acne, dandruff, and dry feet. This will be Kamedis first U.S. patent.
Customers
https://www.emaxhealth.com/13955/why-kamedis-clinically-proven-reduce-eczema-50
growth-positive
A Gentle Approach to Acne
Kamedis Bio-Herbal Skin Care, an Israeli-based company, has made its US debut with prebiotics-based formulas for dandruff, eczema, and acne. The company aims to provide a formula that works effectively but is gentle on the skin, as current OTC remedies can cause irritation. Sales of OTC acne products have only risen by 0.4% in the past year, indicating a need for better solutions. Kamedis offers products derived from botanicals and active OTC ingredients, which trigger the immune system to restore the skins natural balance. The companys products have been clinically proven to reduce flare-ups and dandruff. Kamedis US debut was delayed due to the difficulty of entering the US market, but the company believes there is strong demand for effective, natural solutions.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 0 |
| Investors | 0 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | kamedis.com/ |
| Google Play | Google Play |
Locations
Dvora HaNevi'a Street 121, Tel Aviv-Yafo, Israel
Photos & Videos
3 item(s)
Kamedis Business
Business models
B2C, B2B2C, B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringCosmetic MaterialsTarget Customer
Healthcare & Life SciencesLife SciencesCosmeticsBiotechnologyCommerce & RetailConsumer GoodsBeauty & CosmeticsCore Technology
BiologicalsHerbalsTags (14)
alternative-medicineskin-carebabieschildrendermatologytopical-treatmentherbal-medicineacnecosmeticsallergypharmaceuticalse-healthecommercechronic-patientsGeographic Markets
PhilippinesUnited StatesEuropeChinaTaiwanSwitzerlandGermanySingaporeHong KongRussiaKamedis Financials
Undisclosed
Total funding
—
Capital raised
Undisclosed
Last funding
Mature
Funding stage
0
Total rounds
0
Investors
Kamedis Lifecycle
Kamedis News
14 articles
growth-positive
Eczema patients with dark skin do better with botanical-based treatment Atlanta Daily World
Kamedis Botanical-based Eczema Therapy Cream is more effective in treating atopic dermatitis in skin of color compared to non-botanical OTC products, according to a study. The product demonstrated higher efficacy in improving skin appearance and reducing affected disease area. Atopic dermatitis is prevalent among African-Americans, especially children. The study results highlight the effectiveness of Kamedis patented formulation containing Chinese Rhubarb, Great Burnet, Tree of Heaven, Baikal Skullcap, Cnidium Fruit, and Licorice extracts. The findings provide a potential growth opportunity for Kamedis in the skincare market.
Customers
growth-positive
Kamedis Clinical Study Validates Traditional Chinese Botanical Efficacy in Eczema Treatment
Kamedis, a provider of advanced botanical solutions for chronic skin disorders, has announced the results of a clinical study confirming the efficacy of traditional Chinese botanicals in its over-the-counter Kamedis Calm Eczema Therapy Cream. The study found that the cream was 44% more effective in treating atopic dermatitis than the Kamedis formula without the botanical extracts, and 23% more effective than a competitive OTC brand. The study is the first in the U.S. to determine the efficacy of traditional Chinese botanicals in commercial dermatologic treatments.
Customers
growth-positive
Kamedis Receives Notice of Allowance for First US Patent on Botanical Eczema Treatment
Kamedis has received a Notice of Allowance for a patent application involving their Kamedis Calm Eczema Therapy Cream. The patent will protect the products proprietary combination of traditional Chinese botanicals used to treat eczema-related inflammation and infection. The cream has been clinically proven to reduce eczema flare-ups by 50% in two weeks. Kamedis is also conducting a clinical trial to examine the effectiveness of the botanical ingredients in the healing process. The companys product line includes botanical-based treatments for acne, dandruff, and dry feet. This will be Kamedis first U.S. patent.
Customers
https://www.emaxhealth.com/13955/why-kamedis-clinically-proven-reduce-eczema-50
growth-positive
A Gentle Approach to Acne
Kamedis Bio-Herbal Skin Care, an Israeli-based company, has made its US debut with prebiotics-based formulas for dandruff, eczema, and acne. The company aims to provide a formula that works effectively but is gentle on the skin, as current OTC remedies can cause irritation. Sales of OTC acne products have only risen by 0.4% in the past year, indicating a need for better solutions. Kamedis offers products derived from botanicals and active OTC ingredients, which trigger the immune system to restore the skins natural balance. The companys products have been clinically proven to reduce flare-ups and dandruff. Kamedis US debut was delayed due to the difficulty of entering the US market, but the company believes there is strong demand for effective, natural solutions.
Customers
growth-positive
Kamedis launches in US with botanical personal care line for eczema, acne, and dandruff
Kamedis, a botanical skincare brand, is launching in the US with three skin treatment collections that have undergone clinical testing. The collections aim to address issues such as eczema, acne, and dandruff. Kamedis products are made without certain ingredients like benzoyl peroxide and parabens. The companys products are being manufactured in the US and will be sold through various retailers, including Amazon. The skincare market has seen recent activity in both the sensitive skin care and natural skin care spaces, with companies like Nestlé Skin Health and Burts Bees expanding their product lines.
CustomersPartners
growth-positive
Israeli Botanical Company Releases Skin Remedies in US
Israeli-based company Kamedis has introduced a line of over-the-counter products that use ancient Chinese medicine to heal problem skin. The products have been clinically proven to reduce eczema flare-ups, acne lesions, and dandruff without the side effects of conventional treatments. Kamedis sells its products in Israel and recently introduced them in the US. The company is experiencing growth and has doubled sales in Israel. The global market for plant-derived drugs is expected to reach nearly $40 billion by 2022.
Customers
growth-positive
Not their mom's skin care regimen
The article discusses the changing trends in the skin care category, with a focus on the demand for natural and plant-based ingredients, as well as the preferences of millennials. The article highlights the growth of the skin care market and the opportunities for drug stores to cater to the younger shopper. Sundial Brands, based in Amityville, N.Y., is mentioned as an example of a company that has launched innovative products targeted at millennials. The article emphasizes the importance of natural ingredients and transparency in skin care products, as well as the need for in-store education and a fun shopping experience. The date of the event described in the article is not provided.
Customers
growth-positive
Q&A: Her derma-devotion to Chinese herbs begat a global brand
The article features an interview with Roni Kramer, the Founder and CEO of Kamedis, a herbal skin-care company that combines Chinese medicine with Western pharmacology and biochemistry. Kramer discusses her journey from studying Chinese medicine in San Francisco to practicing in China and eventually starting Kamedis in Israel. The company offers natural and effective products validated with no side effects. Kamedis has achieved significant growth and currently distributes its products in Israel, China, Taiwan, Hong Kong, Switzerland, the Philippines, and the U.S. The article highlights the success of Kamedis Chinese medicine-based products in the Chinese market. Kramer expresses her passion for helping people and the satisfaction she derives from positive customer testimonials. The interview also mentions Kramers affinity for San Francisco and her plans to move back to Israel.
CustomersExpand
growth-positive
Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion
A study funded by Kamedis Ltd. has found that the companys herbal and zinc pyrithione shampoo and scalp lotion are effective in treating scalp seborrheic dermatitis and dandruff. The study, which involved 50 subjects, found that the products improved all evaluated parameters of the conditions, with no safety concerns reported. The products, which are based on herbal botanical ingredients, also contain zinc pyrithione, a commonly used antifungal agent in the treatment of dandruff and seborrheic dermatitis.
Customers
Here's The 3-Step Routine That Calmed My Seborrheic Dermatitis For Good
Neutral
5 Natural Remedies for Eczema That Are Backed by Science
Urban Outfitters has published an article discussing natural remedies for eczema, a skin condition that can range from a minor inconvenience to a constant nuisance. The article, which features advice from dermatologist Dan Siegel, covers a range of topics including the use of plant-based treatments, the importance of keeping skin moisturized, the role of food allergies, and the benefits of natural cleansers. Siegel also advises against over-scrubbing in the shower and notes that while natural remedies can be effective, prescription treatments may be necessary in severe cases.
None
https://www.emaxhealth.com/13955/new-eczema-cream-kamedis-produces-amazing-clinical-results
Expert Gives Tips To Combat Eczema, Acne, Psoriasis
Kamedis Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 42 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 13 classification IDs that could be used for matching.
Kamedis Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 98/100 |
| Missing | funding rounds |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 512682733 |
| Crunchbase | kamedis |
| Phone | +97235124500 |
| Last updater | Paul Weisko |
| Updater email | pweisko@gmail.com |
| Last update | 2021-03-17T00:00:00.000Z |
| Created | 2016-01-18T00:00:00.000Z |
| Claimed | Yes |